A detailed history of Bank Of America Corp transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Bank Of America Corp holds 54,885 shares of MGTX stock, worth $319,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,885
Previous 33,531 63.68%
Holding current value
$319,430
Previous $141,000 61.7%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.88 - $5.23 $82,853 - $111,681
21,354 Added 63.68%
54,885 $228,000
Q2 2024

Aug 14, 2024

SELL
$4.21 - $5.81 $189,917 - $262,094
-45,111 Reduced 57.36%
33,531 $141,000
Q1 2024

May 15, 2024

BUY
$5.78 - $7.33 $170,197 - $215,839
29,446 Added 59.85%
78,642 $477,000
Q4 2023

Feb 14, 2024

BUY
$3.6 - $7.15 $106,261 - $211,046
29,517 Added 149.99%
49,196 $345,000
Q2 2023

Aug 14, 2023

SELL
$5.19 - $8.07 $194,240 - $302,027
-37,426 Reduced 65.54%
19,679 $132,000
Q1 2023

May 12, 2023

SELL
$5.04 - $8.6 $287 - $490
-57 Reduced 0.1%
57,105 $295,000
Q4 2022

Feb 10, 2023

BUY
$5.8 - $8.98 $163,223 - $252,715
28,142 Added 96.97%
57,162 $372,000
Q3 2022

Nov 14, 2022

SELL
$7.55 - $11.25 $17,123 - $25,515
-2,268 Reduced 7.25%
29,020 $244,000
Q2 2022

Aug 12, 2022

SELL
$6.8 - $14.23 $208,583 - $436,491
-30,674 Reduced 49.5%
31,288 $0
Q1 2022

May 16, 2022

BUY
$13.42 - $23.38 $537,095 - $935,714
40,022 Added 182.42%
61,962 $858,000
Q4 2021

Feb 08, 2022

SELL
$12.78 - $23.74 $230,857 - $428,839
-18,064 Reduced 45.16%
21,940 $522,000
Q3 2021

Nov 15, 2021

SELL
$11.73 - $16.08 $37,008 - $50,732
-3,155 Reduced 7.31%
40,004 $528,000
Q2 2021

Sep 13, 2021

BUY
$12.85 - $16.2 $554,593 - $699,175
43,159 New
43,159 $669,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $262M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.